Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials.

Samuele Cortese; Maite Ferrin; Daniel Brandeis; Martin Holtmann; Pascal Aggensteiner; David Daley; Paramala Santosh; Emily Simonoff; Jim Stevenson; Argyris Stringaris; Edmund JS Sonuga-Barke; European ADHD Guidelines Group (EAGG)

Journal article

Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials.

Samuele Cortese, Maite Ferrin, Daniel Brandeis, Martin Holtmann, Pascal Aggensteiner, David Daley, Paramala Santosh, Emily Simonoff, Jim Stevenson, Argyris Stringaris, Edmund JS Sonuga-Barke, undefined European ADHD Guidelines Group (EAGG)

Journal of the American Academy of Child & Adolescent Psychiatry | Published : 2016

DOI: 10.1016/j.jaac.2016.03.007

Abstract

OBJECTIVE: We performed meta-analyses of randomized controlled trials to examine the effects of neurofeedback on attention-deficit/hyperactivity disorder (ADHD) symptoms and neuropsychological deficits in children and adolescents with ADHD. METHOD: We searched PubMed, Ovid, Web of Science, ERIC, and CINAHAL through August 30, 2015. Random-effects models were employed. Studies were evaluated with the Cochrane Risk of Bias tool. RESULTS: We included 13 trials (520 participants with ADHD). Significant effects were found on ADHD symptoms rated by assessors most proximal to the treatment setting, that is, the least blinded outcome measure (standardized mean difference [SMD]: ADHD total symptoms =..

View full abstract